Francisco Javier de la Mata Selected Research

carbosilane

11/2021	Cationic Carbosilane Dendrimers Prevent Abnormal α-Synuclein Accumulation in Parkinson's Disease Patient-Specific Dopamine Neurons.
7/2021	Combined therapy of ruthenium dendrimers and anti-cancer drugs against human leukemic cells.
9/2020	pH-Sensitive Dendrimersomes of Hybrid Triazine-Carbosilane Dendritic Amphiphiles-Smart Vehicles for Drug Delivery.
8/2020	Copper (II) Metallodendrimers Combined with Pro-Apoptotic siRNAs as a Promising Strategy Against Breast Cancer Cells.
6/2020	Ultrastructural Study of Acanthamoeba polyphaga Trophozoites and Cysts Treated In Vitro with Cationic Carbosilane Dendrimers.
6/2020	Ruthenium Dendrimers against Human Lymphoblastic Leukemia 1301 Cells.
1/2020	Generation Dependent Effects and Entrance to Mitochondria of Hybrid Dendrimers on Normal and Cancer Neuronal Cells In Vitro.
1/2019	Ruthenium dendrimers against acute promyelocytic leukemia: in vitro studies on HL-60 cells.
1/2018	Anionic Carbosilane Dendrimers Destabilize the GP120-CD4 Complex Blocking HIV-1 Entry and Cell to Cell Fusion.
1/2018	Ruthenium dendrimers as carriers for anticancer siRNA.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francisco Javier de la Mata Research Topics

Disease

9	Neoplasms (Cancer) 09/2021 - 05/2015
3	Infections 01/2018 - 09/2015
2	Cysts 06/2020 - 02/2015
2	Leukemia 06/2020 - 01/2019
2	HIV Infections (HIV Infection) 01/2017 - 01/2016
1	Parkinson Disease (Parkinson's Disease) 11/2021
1	Breast Neoplasms (Breast Cancer) 08/2020
1	Acanthamoeba Keratitis 06/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2020
1	Neuroblastoma 01/2020
1	Glioma (Gliomas) 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Acute Promyelocytic Leukemia 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2015

Drug/Important Bio-Agent (IBA)

13	Dendrimers (Dendrons)IBA 11/2021 - 02/2015
12	carbosilaneIBA 11/2021 - 02/2015
4	RutheniumIBA 07/2021 - 01/2018
4	Small Interfering RNA (siRNA)IBA 08/2020 - 05/2015
2	Drug CarriersIBA 09/2020 - 01/2020
2	Pharmaceutical PreparationsIBA 09/2020 - 06/2020
1	SynucleinsIBA 11/2021
1	GoldIBA 09/2021
1	Proteins (Proteins, Gene)FDA Link 09/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2021
1	Methotrexate (Mexate)FDA LinkGeneric 07/2021
1	TriazinesIBA 09/2020
1	CopperIBA 08/2020
1	ChlorhexidineIBA 06/2020
1	PrionsIBA 01/2020
1	Phosphorus (Red Phosphorus)IBA 01/2020
1	ViologensIBA 01/2020
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2020
1	PolymersIBA 01/2016
1	Lysine (L-Lysine)FDA Link 01/2016
1	Anti-Infective Agents (Microbicides)IBA 01/2016
1	Antiviral Agents (Antivirals)IBA 09/2015

Therapy/Procedure

4	Therapeutics 07/2021 - 05/2015